$736 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 104 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 75.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COLL | Sell | COLLEGIUM PHARMACEUT | $19,865,000 | -32.3% | 1,156,934 | -41.8% | 2.70% | -13.3% |
| PFE | Sell | PFIZER INC | $18,565,000 | -6.4% | 425,326 | -5.5% | 2.52% | +19.9% |
| NVS | Sell | NOVARTIS AGadr | $18,316,000 | -6.4% | 213,446 | -6.0% | 2.49% | +19.8% |
| UNH | Sell | UNITEDHEALTH GRP INC | $10,913,000 | -29.0% | 43,806 | -24.2% | 1.48% | -9.2% |
| MDT | Sell | MEDTRONIC PLC | $10,683,000 | -17.0% | 117,451 | -10.2% | 1.45% | +6.2% |
| XLRN | Sell | ACCELERON PHARMA | $9,221,000 | -46.1% | 211,726 | -29.1% | 1.25% | -31.0% |
| BSX | Sell | BOSTON SCIENTIFIC | $8,548,000 | -11.7% | 241,876 | -3.8% | 1.16% | +13.1% |
| EXAS | Sell | EXACT SCIENCES CORP | $8,465,000 | -58.9% | 134,150 | -48.6% | 1.15% | -47.4% |
| Sell | INTEC PHARMA LTD JER | $8,341,000 | +25.4% | 1,106,175 | -6.0% | 1.13% | +60.6% | |
| BMRN | Sell | BIOMARIN PHARMAC INC | $7,802,000 | -56.4% | 91,621 | -50.4% | 1.06% | -44.2% |
| ABMD | Sell | ABIOMED INC | $7,290,000 | -43.5% | 22,427 | -21.8% | 0.99% | -27.6% |
| ABT | Sell | ABBOTT LABS | $7,059,000 | -12.0% | 97,598 | -10.8% | 0.96% | +12.7% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $6,767,000 | -50.6% | 97,400 | -32.7% | 0.92% | -36.7% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $6,002,000 | -59.5% | 36,217 | -52.9% | 0.82% | -48.1% |
| NITE | Sell | NIGHTSTAR THERAPEUadr | $2,692,000 | -44.7% | 233,711 | -1.9% | 0.37% | -29.2% |
| SBPH | Sell | SPRING BK PHARMACE | $2,615,000 | -25.6% | 251,656 | -13.7% | 0.36% | -4.8% |
| JNJ | Sell | JOHNSON & JOHNSON | $2,297,000 | -88.1% | 17,799 | -87.2% | 0.31% | -84.7% |
| ALDR | Sell | ALDER BIOPHARMACEU | $1,315,000 | -87.0% | 128,300 | -79.0% | 0.18% | -83.4% |
| ANTM | Sell | ANTHEM INC | $883,000 | -5.0% | 3,361 | -0.9% | 0.12% | +21.2% |
| RDY | Sell | DR REDDYS LABS LTDadr | $682,000 | -8.7% | 18,097 | -16.2% | 0.09% | +17.7% |
| ZLAB | Sell | ZAI LAB LTDadr | $292,000 | -66.7% | 12,589 | -72.0% | 0.04% | -57.0% |
| CNC | Sell | CENTENE CORP DEL | $240,000 | -20.8% | 2,080 | -0.5% | 0.03% | +3.1% |
| AGRX | Exit | AGILE THERAPEUTICS | $0 | – | -45,000 | -100.0% | -0.00% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES | $0 | – | -32,936 | -100.0% | -0.00% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS | $0 | – | -12,000 | -100.0% | -0.00% | – |
| SLNO | Exit | SOLENO THERAPEUTICS | $0 | – | -21,587 | -100.0% | -0.01% | – |
| CNAT | Exit | CONATUS PHARMACEUTICALS | $0 | – | -10,364 | -100.0% | -0.01% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALSsp adr | $0 | – | -15,218 | -100.0% | -0.01% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -32,241 | -100.0% | -0.01% | – |
| Exit | PROTAGONIST THERAPEUTICS | $0 | – | -11,400 | -100.0% | -0.01% | – | |
| PGNX | Exit | PROGENICS PHARMACEUTICALS | $0 | – | -18,002 | -100.0% | -0.01% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS | $0 | – | -12,739 | -100.0% | -0.01% | – |
| AVEO | Exit | AVEO PHARMACUTICALS | $0 | – | -36,000 | -100.0% | -0.01% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -18,921 | -100.0% | -0.02% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS | $0 | – | -12,957 | -100.0% | -0.02% | – |
| BDSI | Exit | BIODELIVERY SCIENCES | $0 | – | -54,434 | -100.0% | -0.02% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS | $0 | – | -15,367 | -100.0% | -0.02% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES | $0 | – | -12,609 | -100.0% | -0.02% | – |
| AMRX | Exit | AMNEAL PHARMACEUTICALS | $0 | – | -9,040 | -100.0% | -0.02% | – |
| GTHX | Exit | G1 THERAPEUTICS | $0 | – | -3,857 | -100.0% | -0.02% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS | $0 | – | -13,920 | -100.0% | -0.02% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -2,975 | -100.0% | -0.02% | – |
| TEVA | Exit | TEVA PHARMACEUTICALsp adr | $0 | – | -10,120 | -100.0% | -0.02% | – |
| AET | Exit | AETNA INC | $0 | – | -1,143 | -100.0% | -0.02% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -13,141 | -100.0% | -0.02% | – |
| SHPG | Exit | SHIRE PLCsp adr | $0 | – | -1,300 | -100.0% | -0.02% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE | $0 | – | -3,418 | -100.0% | -0.03% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -3,298 | -100.0% | -0.03% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -4,841 | -100.0% | -0.03% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -3,533 | -100.0% | -0.03% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -4,051 | -100.0% | -0.03% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA | $0 | – | -7,945 | -100.0% | -0.03% | – |
| STE | Exit | STERIS PLC | $0 | – | -2,406 | -100.0% | -0.03% | – |
| ICLR | Exit | ICON PLC | $0 | – | -1,780 | -100.0% | -0.03% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS | $0 | – | -15,400 | -100.0% | -0.03% | – |
| AZN | Exit | ASTRAZENECAsp adr | $0 | – | -7,100 | -100.0% | -0.03% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsp adr | $0 | – | -7,300 | -100.0% | -0.03% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -10,226 | -100.0% | -0.03% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -9,614 | -100.0% | -0.03% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -10,036 | -100.0% | -0.03% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS | $0 | – | -98,609 | -100.0% | -0.03% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS | $0 | – | -7,208 | -100.0% | -0.04% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -6,171 | -100.0% | -0.04% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -626 | -100.0% | -0.04% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICAKS | $0 | – | -13,458 | -100.0% | -0.04% | – |
| AKCA | Exit | AKCEA THERAPEUTICS | $0 | – | -10,356 | -100.0% | -0.04% | – |
| DHR | Exit | DANAHER CORP | $0 | – | -3,556 | -100.0% | -0.04% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -2,957 | -100.0% | -0.05% | – |
| HRTX | Exit | HERON THERAPEUTICS | $0 | – | -15,243 | -100.0% | -0.05% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -3,724 | -100.0% | -0.05% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -3,842 | -100.0% | -0.05% | – |
| MYL | Exit | MYLAN N V | $0 | – | -14,329 | -100.0% | -0.06% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -3,195 | -100.0% | -0.06% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -1,370 | -100.0% | -0.06% | – |
| Exit | EDWARDS LIFESCIENCES | $0 | – | -3,705 | -100.0% | -0.07% | – | |
| INCY | Exit | INCYTE CORPORATION | $0 | – | -11,113 | -100.0% | -0.08% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES | $0 | – | -6,803 | -100.0% | -0.09% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -20,585 | -100.0% | -0.09% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -57,144 | -100.0% | -0.10% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS | $0 | – | -123,405 | -100.0% | -0.15% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -7,771 | -100.0% | -0.16% | – |
| FIXX | Exit | HOMOLOGY MEDICINES | $0 | – | -143,487 | -100.0% | -0.35% | – |
| ESPR | Exit | ESPERION THERAPEUTICS | $0 | – | -96,100 | -100.0% | -0.45% | – |
| AGIO | Exit | AGIOS PHARMACEUTICS | $0 | – | -56,207 | -100.0% | -0.46% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS | $0 | – | -27,000 | -100.0% | -0.46% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -35,102 | -100.0% | -0.46% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -82,263 | -100.0% | -0.53% | – |
| CI | Exit | CIGNA CORP | $0 | – | -46,530 | -100.0% | -1.03% | – |
| ALXN | Exit | ALEXION PHARM INC | $0 | – | -88,399 | -100.0% | -1.30% | – |
| CLVS | Exit | CLOVIS ONCOLOGY | $0 | – | -443,397 | -100.0% | -1.38% | – |
| KTWO | Exit | K2M GROUP HOLDINGS | $0 | – | -906,741 | -100.0% | -2.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.